Complementing Tissue Testing with Plasma mutation Profiling Improves Therapeutic Decision Making for Lung Cancer Patients

Yukti Choudhury, Min-Han Tan, Jun Li Shi, Augustine Tee, Kao Chin Ngeow, Jonathan Poh, Ruth Rosalyn Goh, Jamie Mong
doi: https://doi.org/10.1101/2021.08.04.21261589

Article Information

doi 
https://doi.org/10.1101/2021.08.04.21261589
History 
  • August 5, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Yukti Choudhury1,
  2. Min-Han Tan1,
  3. Jun Li Shi2,
  4. Augustine Tee3,
  5. Kao Chin Ngeow1,
  6. Jonathan Poh1,
  7. Ruth Rosalyn Goh1,4 and
  8. Jamie Mong2,‡
  1. 1Lucence Diagnostics Pte. Ltd., Singapore
  2. 2Institute of Bioengineering and Nanotechnology, Singapore
  3. 3Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore
  4. 4Faculty of Medicine, Imperial College London
  1. ↵‡Corresponding author: jmong{at}ibb.a-star.edu.sg
Back to top
Posted August 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Complementing Tissue Testing with Plasma mutation Profiling Improves Therapeutic Decision Making for Lung Cancer Patients
Yukti Choudhury, Min-Han Tan, Jun Li Shi, Augustine Tee, Kao Chin Ngeow, Jonathan Poh, Ruth Rosalyn Goh, Jamie Mong
medRxiv 2021.08.04.21261589; doi: https://doi.org/10.1101/2021.08.04.21261589
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area